House Judiciary panel approves bills to boost drug competition
The House Judiciary Committee approved several bills that would place more restrictions on branded drugmakers that try to limit competition from generic drug companies. The full House could take up the...
Subscription required to view this article.
This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this content